How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin's lymphoma patients?

被引：23

作者：

Coiffier, B ^{[1
]}

机构：

[1] Hosp Civils Lyon, Hematol Serv, Pierre Benite, France

[2] Univ Lyon 1, Pierre Benite, France

来源：

ANNALS OF ONCOLOGY | 1999年 / 10卷 / 10期

关键词：

D O I：

10.1023/A:1008308129857

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1141 / 1143

页数：3

共 21 条

[1] Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDC-PET) for accurate staging of Hodgkin's disease [J].

Bangerter, M ;

Moog, F ;

Buchmann, I ;

Kotzerke, J ;

Griesshammer, M ;

Hafner, M ;

Elsner, K ;

Frickhofen, N ;

Reske, SN ;

Bergmann, L .

ANNALS OF ONCOLOGY, 1998, 9 (10) :1117-1122

[2] Detection of lymphoma in bone marrow by whole-body positron emission tomography [J].

Carr, R ;

Barrington, SF ;

Madan, B ;

O'Doherty, MJ ;

Saunders, CAB ;

van der Walt, J ;

Timothy, AR .

BLOOD, 1998, 91 (09) :3340-3346

[3] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].

Cheson, BD ;

Horning, SJ ;

Coiffier, B ;

Shipp, MA ;

Fisher, RI ;

Connors, JM ;

Lister, TA ;

Vose, J ;

Grillo-López, A ;

Hagenbeek, A ;

Cabanillas, F ;

Klippensten, D ;

Hiddemann, W ;

Castellino, R ;

Harris, NL ;

Armitage, JO ;

Carter, W ;

Hoppe, R ;

Canellos, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253

[4] PROGNOSTIC FACTORS IN AGGRESSIVE MALIGNANT-LYMPHOMAS - DESCRIPTION AND VALIDATION OF A PROGNOSTIC INDEX THAT COULD IDENTIFY PATIENTS REQUIRING A MORE INTENSIVE THERAPY [J].

COIFFIER, B ;

GISSELBRECHT, C ;

VOSE, JM ;

TILLY, H ;

HERBRECHT, R ;

BOSLY, A ;

ARMITAGE, JO .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) :211-219

[5] THE ROLE OF GA-67 SCINTIGRAPHY IN EVALUATING THE RESULTS OF THERAPY OF LYMPHOMA PATIENTS [J].

FRONT, D ;

ISRAEL, O .

SEMINARS IN NUCLEAR MEDICINE, 1995, 25 (01) :60-71

[6] ROLE OF MAGNETIC-RESONANCE-IMAGING IN PREDICTING RELAPSE IN RESIDUAL MASSES AFTER TREATMENT OF LYMPHOMA [J].

HILL, M ;

CUNNINGHAM, D ;

MACVICAR, D ;

ROLDAN, A ;

HUSBAND, J ;

MCCREADY, R ;

MANSI, J ;

MILAN, S ;

HICKISH, T .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) :2273-2278

[7] Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy [J].

Janicek, M ;

Kaplan, W ;

Neuberg, D ;

Canellos, GP ;

Shulman, LN ;

Shipp, MA .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1631-1637

[8] Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging [J].

Jerusalem, G ;

Beguin, Y ;

Fassotte, MF ;

Najjar, F ;

Paulus, P ;

Rigo, P ;

Fillet, G .

BLOOD, 1999, 94 (02) :429-433

[9] GA-67 IMAGING - A PREDICTOR OF RESIDUAL TUMOR VIABILITY AND CLINICAL OUTCOME IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA [J].

KAPLAN, WD ;

JOCHELSON, MS ;

HERMAN, TS ;

NADLER, LM ;

STOMPER, PC ;

TAKVORIAN, T ;

ANDERSEN, JW ;

CANELLOS, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (12) :1966-1970

[10] THE SIGNIFICANCE OF ISOLATED GA-67 UPTAKE IN THE HILAR LYMPH-NODES OF AN UNTREATED LYMPHOMA PATIENT [J].

LARCOS, G ;

FARLOW, DC ;

ANTICO, VF ;

GRUENEWALD, SM .

CLINICAL NUCLEAR MEDICINE, 1993, 18 (12) :1039-1041

← 1 2 3 →